Search for: "ENDO INTERNATIONAL, PLC" Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Oct 2014, 11:04 am by Pete Strom
Endo Pharmaceuticals Reaches Settlement Agreement with Transvaginal Mesh Victims On Tuesday, September 30th, Endo International Plc stated that the medical device manufacturer had agreed to a settlement involving 20,000 transvaginal mesh personal injury claims, ending all of the cases against its American Medical Systems unit, which were going to trial in a multidistrict litigation (MDL). [read post]
Endo International PLC (Endo) Tuesday agreed to pay $65 million to settle all Florida governmental opioid-related cases and claims, preventing pending claims against the specialty pharmaceutical company from going to trial. [read post]
20 May 2015, 1:00 am by Paul Caron
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
30 Jan 2019, 5:06 am by Sara E. Teller
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
11 Aug 2017, 8:31 am by Naumes Law
On August 7, Endo International Plc agreed to a settlement amount of an additional $775 million that will allow the company to settle the remaining 22,000 mesh suits brought against them. [read post]
3 Jun 2014, 1:05 pm by Joshua L. Firth
On April 30th, Endo International Plc (“Endo”) agreed to pay $830 million to resolve legal claims filed by women who have been injured by various transvaginal mesh devices. [read post]
3 Jun 2014, 1:05 pm by Joshua L. Firth
On April 30th, Endo International Plc (“Endo”) agreed to pay $830 million to resolve legal claims filed by women who have been injured by various transvaginal mesh devices. [read post]
6 Jun 2016, 4:16 pm by Jay W. Belle Isle
AMS, owned by Endo International PLC, faced litigation due to injuries caused by its vaginal mesh devices, including the Apogee and Perigee systems, as well as the MiniArcThe post American Medical Systems Settles over 100 Pelvic Mesh Suits appeared first on Legal Reader. [read post]
21 Jun 2017, 1:52 pm by Autumn Callan
Purdue Pharma LP, Johnson & Johnson and units of Endo International Plc. [read post]
6 Oct 2014, 4:29 pm by Dr. Shezad Malik
Endo International Plc, the owner of AMS, has agreed to settle its product liability transvaginal mesh lawsuits that allege its line of vaginal-mesh implants caused personal injury by eroding through the vagina in some women and left them in pain and exposed to serious infections. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
  The third of the three generic drug companies to be sued in a follow-on securities class action lawsuit was Endo International plc. [read post]
4 Dec 2017, 6:38 am by Robert Kraft
It also follows the Food and Drug Administration’s request that Endo International Plc withdraw its opioid painkiller from the market. [read post]
2 Jan 2015, 8:42 am by admin
Endo International Plc agreed to pay $1.3 billion in the settlement. [read post]
6 Feb 2015, 2:07 pm
In 2014, Endo International Plc subsidiary American Medical Systems put aside $1.6 billion to resolve 20,000 transvaginal mesh cases plus other unfiled claims. [read post]
1 Jul 2014, 6:16 am by CSSFIRM.COM
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]
4 Jan 2017, 8:26 am by Molly Crabtree
 It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc and various predecessors and executives. [read post]
4 Jan 2017, 8:26 am by Molly Crabtree
  It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc, and various predecessors and executives. [read post]
30 Aug 2014, 7:38 am by Dr. Shezad Malik
Endo International Plc (ENDP) agreed this year to pay $830 million to resolve about 20,000 suits alleging its vaginal-mesh inserts eroded in some women and left them incontinent and in pain. [read post]